ArticleFrontiers in endocrinology2022

Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study.

Yueyue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.